Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment
Abstract Immune Cell Deconvolution methods utilizing gene expression profiling to quantify immune cells in tissues and blood are an appealing alternative to flow cytometry. Our objective was to investigate the applicability of deconvolution approaches in clinical trial settings to better investigate...
Main Authors: | Irina Kalatskaya, Gavin Giovannoni, Thomas Leist, Joseph Cerra, Ursula Boschert, P. Alexander Rolfe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-34384-5 |
Similar Items
-
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
by: Peter Rieckmann, et al.
Published: (2021-12-01) -
Immunomodulatory Effects Associated with Cladribine Treatment
by: Nicolás Fissolo, et al.
Published: (2021-12-01) -
Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-02-01) -
Performing a physiologically relevant test for cladribine tablets
by: P. A. Losenkova, et al.
Published: (2024-09-01) -
Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design
by: Peter V. Sguigna, et al.
Published: (2024-04-01)